About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 157 record(s)
Req # A-2022-000317
Adverse Drug Reaction (ADR). Report number: E2B_05216421.Organization: Health Canada
August 2022
Req # A-2022-000347
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-102150-942.Organization: Health Canada
August 2022
Req # A-2022-000349
Adverse Drug Reactions (ADRs). Report numbers: 000988444, E2B_04890759, 000986965, E2B_05225417, 000989721.Organization: Health Canada
August 2022
Req # A-2022-000366
Adverse Drug Reactions (ADRs) for Aripiprazole. Report numbers: 000980935, 000982198, E2B_05016280, 000982365, E2B_05196198, E2B_05158895. ADRs for Rexulti. report numbers: E2B_05028665, E2B_05181034, E2B_05144706. ADR for SUCROFERRIC OXYHYDROXIDE…Organization: Health Canada
August 2022
Req # A-2022-000367
Adverse Drug Reactions (ADRs) for PATIROMER. Report numbers: E2B_04967152, E2B_04972001, E2B_05015051, E2B_05028325, E2B_05028332, E2B_05106567, E2B_05130404, E2B_05162209, E2B_05162212, E2B_05162575.Organization: Health Canada
August 2022
Req # A-2022-000383
Adverse Drug Reactions (ADRs). Report numbers: E2B_04230965, E2B_000961684, E2B_000960285, E2B_04280387, 000969801, E2B_05308694, E2B_05271841, E2B_04938853, E2B_03464479, E2B_03468325.Organization: Health Canada
August 2022
Req # A-2022-000385
Adverse Drug Reactions (ADRs). Report numbers: E2B_05275337, 000988623, 000987651, E2B_05259820, 000988396, E2B_05213794, 000986977, E2B_05235640, E2B_05245522, E2B_05281998.Organization: Health Canada
August 2022
Req # A-2022-000386
Adverse Drug Reactions (ADRs). Report numbers: E2B_03464446, E2B_03464469, E2B_03468310, E2B_03473080, E2B_03665136, E2B_03464442, E2B_03468294, E2B_04501633, E2B_03464445, E2B_04411529.Organization: Health Canada
August 2022
Req # A-2022-000388
Adverse Drug Reactions (ADRs). Report numbers: 000936560, 000952708, E2B_05271391.Organization: Health Canada
August 2022
Req # A-2022-000401
Adverse Drug Reactions (ADRs). Report numbers: E2B_03468319, E2B_03462681, E2B_03464451, E2B_03464474, E2B_03464489, E2B_03464487, E2B_03566985.Organization: Health Canada
August 2022